PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1429.41%
Some net income increase while AVGO is negative at -616.67%. John Neff would see a short-term edge over the struggling competitor.
-2.92%
Both reduce yoy D&A, with AVGO at -4.88%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
100.00%
Deferred tax of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-6.00%
Negative yoy SBC while AVGO is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
80.61%
Less working capital growth vs. AVGO's 198.04%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
46.79%
AR growth is negative or stable vs. AVGO's 104.17%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
-86.74%
Negative yoy inventory while AVGO is 180.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
100.00%
AP growth well above AVGO's 120.00%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
250.00%
Growth well above AVGO's 162.50%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-23.08%
Negative yoy while AVGO is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
121.91%
Operating cash flow growth below 50% of AVGO's 1750.00%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-11.63%
Both yoy lines negative, with AVGO at -8.33%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
50.96%
Acquisition growth of 50.96% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-55.86%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-19.81%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-60.88%
Both yoy lines negative, with AVGO at -50.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to AVGO's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
5.56%
Issuance growth of 5.56% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-147.52%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.